Literature DB >> 10437866

Long-term outcome in children after antenatal intervention for obstructive uropathies.

A L Freedman1, M P Johnson, C A Smith, R Gonzalez, M I Evans.   

Abstract

BACKGROUND: Antenatal intervention has been done for fetal obstructive uropathy for over a decade, yet little is known about long-term outcomes. To assess the long-term implications of fetal intervention, we reviewed the outcomes of children who underwent vesicoamniotic shunt placement.
METHODS: We reviewed the clinical outcomes of 14 children who underwent vesicoamniotic shunt placement at our institution and who survived beyond 2 years of age.
FINDINGS: In 1987-96, 34 patients underwent vesicoamniotic shunt placement. 13 died and 21 survived, of whom 17 are now more than 2 years old. Three survivors were lost to follow-up. Mean age at follow-up was 54.3 months (range 25-114). Final diagnoses included prune belly syndrome (seven cases), posterior urethral valves (four), urethral atresia (one), vesicoureteral reflux (one), and megacystis (one). Height was below the 25th percentile in 12 (86%) with seven (50%) below the 5th percentile. Five (36%) had renal failure and had successful transplantation, three (21%) have renal insufficiency, and six (43%) have normal renal function. Seven (50%) are acceptably continent, five (36%) have not yet begun toilet-training, and two (14%) are incontinent. Three of four children with valves needed bladder augmentation.
INTERPRETATION: Antenatal intervention may help those fetuses with the most severe forms of obstructive uropathy, usually associated with a fatal neonatal course. Intervention achieves outcomes similar to less severe cases that are usually diagnosed postnatally.

Entities:  

Mesh:

Year:  1999        PMID: 10437866     DOI: 10.1016/S0140-6736(98)11006-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  Management of fetal hydronephrosis.

Authors:  Jenny Yiee; Duncan Wilcox
Journal:  Pediatr Nephrol       Date:  2007-08-02       Impact factor: 3.714

Review 2.  Prognosis of antenatally diagnosed oligohydramnios of renal origin.

Authors:  Markus J Kemper; Dirk E Mueller-Wiefel
Journal:  Eur J Pediatr       Date:  2007-01-05       Impact factor: 3.183

3.  Need for national fetal screening programme for congenital anomalies.

Authors:  K L Narasimhan; Rizwan A Khan
Journal:  Indian J Pediatr       Date:  2009-10       Impact factor: 1.967

Review 4.  Lower urinary tract obstruction: fetal intervention based on prenatal staging.

Authors:  Rodrigo Ruano; Timothy Dunn; Michael C Braun; Joseph R Angelo; Adnan Safdar
Journal:  Pediatr Nephrol       Date:  2017-07-21       Impact factor: 3.714

Review 5.  Fetal surgery: a critical review.

Authors:  H Kitagawa; K C Pringle
Journal:  Pediatr Surg Int       Date:  2017-01-05       Impact factor: 1.827

6.  Valved shunt as a treatment for obstructive uropathy: does pressure make a difference?

Authors:  Hiroaki Kitagawa; Yasuji Seki; Hideki Nagae; Takeshi Aoba; Shutaro Manabe; Kei Ooyama; Junki Koike; Masayuki Takagi; Jane Zuccollo; Shinobu Tatsunami; Kevin C Pringle
Journal:  Pediatr Surg Int       Date:  2013-04       Impact factor: 1.827

7.  Development of an animal model to study congenital urinary obstruction.

Authors:  K C Pringle; H Kitagawa; Y Seki; J Koike; J Zuccollo
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

8.  Antenatally Diagnosed Posterior Urethral Valves: A Dilemma.

Authors:  R Panicker; D S Grewal
Journal:  Med J Armed Forces India       Date:  2011-07-21

9.  Early bladder wall changes after creation of obstructive uropathy in the fetal lamb.

Authors:  Hiroaki Kitagawa; Kevin C Pringle; Junki Koike; Hideki Nagae; Jane Zuccollo; Yuriko Sato; Yasuji Seki; Shinichirou Fujiwaki; Munechika Wakisaka; Koonosuke Nakada
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

Review 10.  Severe antenatally diagnosed renal disorders: background, prognosis and practical approach.

Authors:  Wiebke Aulbert; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2015-06-17       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.